fotemustine has been researched along with Carcinoma, Non-Small Cell Lung in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addeo, R; Caraglia, M; Facchini, S; Luce, A; Zappavigna, S | 1 |
| Adamo, V; Calista, F; Carrozza, F; Cigolari, S; Colucci, G; Ferraù, F; Galetta, D; Gebbia, V; Russo, P; Silvestris, N | 1 |
| Grant, SC; Kris, MG | 1 |
| Astoul, P; Boutin, C; Juin, P; Muracciole, X; Orabona, P; Pignon, T; Ruggieri, S; Vialette, JP | 1 |
| Berille, J; Bertrand, P; Bizzari, JP; Cour, V; Gerard, B; Giroux, B; Khayat, D; Sarkany, M | 1 |
| Allen, R; Berille, J; Rudd, R; Souhami, RL; Spiro, SG; Trask, C | 1 |
| Baio, S; Berille, J; Le Cesne, A; Le Chevalier, T; Rivière, A | 1 |
| Berille, J; Bizzari, JP; Cerrina, ML; Douillard, JY; Gouva, S; Grandgirard, A; Le Chevalier, T; Monnier, A; Pujol, JL; Rivière, A | 1 |
| Baud, M; Bérille, J; Chabot, G; Gouyette, A; Le Cesne, A; Le Chevalier, T; Lucas, C; Marty, M | 1 |
| Berille, J; Brune, J; Cotto, C; Croisile, B; Giroux, B; Riou, R; Souquet, PJ; Trillet-Lenoir, V; Turjman, F | 1 |
| Boaziz, C | 1 |
| Berille, J; Berlion, M; Bizzari, JP; Fischel, JL; Formento, P; Gioanni, J; Milano, G | 1 |
4 review(s) available for fotemustine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds | 2013 |
New antineoplastic agents in lung cancer 1988-1993.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine | 1995 |
Fotemustine in the treatment of brain primary tumors and metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Glioma; Humans; Lung Neoplasms; Melanoma; Middle Aged; Multicenter Studies as Topic; Nitrosourea Compounds; Organophosphorus Compounds | 1994 |
[Contribution of a new nitrosourea compound: fotemustine].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dacarbazine; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds | 1992 |
6 trial(s) available for fotemustine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome | 2011 |
Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Quality of Life; Thrombocytopenia | 1994 |
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Nitrosourea Compounds; Organophosphorus Compounds; Vomiting | 1994 |
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Quality of Life; Survival Analysis; Time Factors | 1994 |
Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 1995 |
A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate | 1996 |
2 other study(ies) available for fotemustine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
[Association of radiation- and fotemustine-therapy in the management of brain metastases from non-small-cell cancers of the lung].
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Survival Analysis | 1994 |
Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured | 1991 |